AKT1 and glioblastoma: In fact, the PIK3 inhibitor GDC-0941 has been shown to inhibit AKT phosphorylation of BAD, decrease MCL-1 expression, and inhibit the growth of glioblastoma cells in synergy with ABT-263 [34].